PKO Investment Management Joint-Stock’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,157
Closed -$1.11M 87
2019
Q3
$1.11M Hold
11,157
0.28% 63
2019
Q2
$1.03M Hold
11,157
0.26% 64
2019
Q1
$1.05M Hold
11,157
0.28% 63
2018
Q4
$715K Hold
11,157
0.2% 66
2018
Q3
$998K Hold
11,157
0.2% 63
2018
Q2
$886K Hold
11,157
0.19% 67
2018
Q1
$995K Hold
11,157
0.22% 60
2017
Q4
$1.16M Buy
11,157
+5,827
+109% +$657K 0.29% 55
2017
Q3
$777K Hold
5,330
0.21% 59
2017
Q2
$692K Hold
5,330
0.23% 56
2017
Q1
$663K Buy
5,330
+2,727
+105% +$326K 0.3% 43
2016
Q4
$301K Buy
+2,603
New +$290K 0.2% 38

Other funds holding CELG

PKO Investment Management Joint-Stock's CELG Position: Q4 2019 in Review

PKO Investment Management Joint-Stock sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,157 shares — an estimated $1.11M sold.

PKO Investment Management Joint-Stock first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $1.16M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • PKO Investment Management Joint-Stock reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • PKO Investment Management Joint-Stock sold 11,157 Celgene Corp shares in Q4 2019, an estimated $1.11M.
  • PKO Investment Management Joint-Stock first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • PKO Investment Management Joint-Stock's Celgene Corp position peaked at $1.16M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on PKO Investment Management Joint-Stock's 13F filing for Q4 2019, filed 13 Mar 2025.